Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 1214Triple Negative Breast Neoplasms 216Ovarian Neoplasms 109Carcinoma, Non-Small-Cell Lung 85Colorectal Neoplasms 82Neoplasm Metastasis 78Prostatic Neoplasms 75Neoplasms 68Lung Neoplasms 67Melanoma 56Endometrial Neoplasms 49Stomach Neoplasms 48Pancreatic Neoplasms 48Uterine Cervical Neoplasms 42Squamous Cell Carcinoma of Head and Neck 37Colonic Neoplasms 34Carcinoma, Intraductal, Noninfiltrating 33Carcinoma, Renal Cell 32Head and Neck Neoplasms 30Sarcoma 26Esophageal Neoplasms 25Breast Carcinoma In Situ 24Small Cell Lung Carcinoma 23Brain Neoplasms 22Urinary Bladder Neoplasms 21Carcinoma, Transitional Cell 19Advanced Breast Cancer 19Anatomic Stage I Breast Cancer AJCC v8 17Gastrointestinal Neoplasms 16Thyroid Neoplasms 15

Interventions

trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Cancer Metastatic × Breast × 90 days × Clear all
NCT07586215 2026-05-14

PREDICT-HER

Fudan University

Recruiting
100 enrolled
Breast

Breast Cancer Metastatic

NCT06750484 2026-05-06

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Yale University

Phase 2 Recruiting
40 enrolled
Breast

Breast Cancer Metastatic

NCT06706570 2026-03-24

PIK3CA Mutational Status Assessment

European Institute of Oncology

Recruiting
100 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡